Recent News & Events


NABR Urges Everyone to Contact President Trump and Congress to Voice Support for Biomedical Research!


Your Voice Matters: Contact President Trump and Congress Today!

As the NABR reported last week to their members, the new Congress has already begun business in Washington for its 2017-2019 legislative session. A total of 55 new Freshman Members of Congress from states and districts across the country are now settling-in to legislate on a full slate of issues, including those that impact biomedical research with animal studies.

In order to introduce these new lawmakers to NABR, its membership, and the various issues facing the future of biomedical research, NABR has sent a welcome letter to them and the rest of the 115th Congress. NABR encourages you to do the same. If you'd like to voice your support for biomedical research in this upcoming Congress and Presidential Administration, you can write the President, Vice President, your Senators, your Congressperson and the U.S. Department of Agriculture. This investment of your time will pay significant dividends in terms of educating policy makers about the irreplaceable value of humane animal research.

There's a pre-written letter below that you can send to:

  • The President
  • The Vice President
  • Your U.S. Senators
  • Your U.S. House Representative
  • Kevin Shea, Administrator, Animal and Plant Health Inspection Service
  • Agriculture, Secretary of Agriculture, Secretary

Please Stand-Up and Support Biomedical Research

"I write to introduce myself as a constituent who is a member of the biomedical research community concerned about the future of lifesaving and life improving research.

Despite technological advances in the field of discovery research, animal research remains vital to our mission to understand disease, discover targeted therapies, alleviate suffering and improve and increase the quality of life. Almost every major medical advancement of the last 100 years has depended upon research with these models, including the top 25 most prescribed medications. Peer reviewed studies involving animals are strictly governed by a rigid structure of laws, regulations and guidelines and they have provided irreplaceable knowledge in the process of discovering new therapies to treat, cure, and prevent disease. Immunizations, organ transplants, reconstructive surgeries, and other innovations have been brought to fruition through responsible scientific research with animals. Even cancer studies, like those in the Cancer Moonshot, rely on ethical and humane animal use in the search for a cure to eradicate cancer. Animal models play a significant role in finding interventions for the world's five deadliest diseases and in lowering healthcare costs.

Undoubtedly, you will be asked to review legislative and regulatory initiatives affecting research involving animal models during your term. Animal rights groups, long time opponents to my work, have regularly sought to pass legislation that would handcuff universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups and academic and professional societies in the endeavor to advance veterinary and human health. I ask that you please seriously consider the impact that enactment of such legislation would have upon the lifesaving research protocols that I and thousands of others work on daily.

Please SUPPORT SCIENCE and OPPOSE any short-sighted efforts that would derail significant and revolutionary research.

Should you or your staff have questions about biomedical research, animal law, or animal rights activism against research, please do not hesitate to contact the National Association for Biomedical Research (NABR) at (202) 857-0540 or email This email address is being protected from spambots. You need JavaScript enabled to view it.. On behalf of myself and my colleagues in the biomedical research community, I wish you a rewarding and productive legislative session." - National Association for Biomedical Research (NABR).



Comments (3)

  • Peter Maciukas

    Peter Maciukas

    04 October 2017 at 22:16 |
    Dear DSS - NABR: there is a very valuable cancer medicine being held in interim by CYTR. It is 95% approved in FDA TESTS 3 stage, The CYTR BODs know its future potential and want to take over the whole company through RS and shorting and buying the degraded shares. In the meantime this cancer medicine aldoxorubicin lies in limbo between CYTR and NANTCELL. This medicine will save us govt for medical and will save lives. If this brief description is inadequate please let me know. I know President Trump wants to save lives especially to those we owe the most to, our vets. I am an old man and I want the best for my country.


    • Peter maciukas

      Peter maciukas

      05 October 2017 at 13:26 |
      Dear NABR, My mistake. You are concerned with animal testing. It seems necessary but there is abuse also in the needless duplication of testing by different scientists. My wife and I rescued a least one cat that was to be destroyed after testing. As to your goal in retaining animal testing I do not have an answer. Another matter, the increasing testing and allowing medicines in FDA testing to be used in sick patients who voluntarily desire to try the remedy is the humane way.


      • Super User

        Super User

        12 October 2017 at 11:51 |
        Hi Peter, DSS promotes sharing of test data as well as tissue samples. We report on any programs we find that reduce needless testing to help get the word out. There's an article about SEARCHBreast we did that I think you'll like. Data compiled for their initial reporting showed that their program spared 400 animals! How great is that! Advancements in technology also make it possible to use computer models in certain circumstances. We will hopefully see more and more programs become available that spare as many animals as possible. As for testing on sick patients, I have personal experience with this, and they do Fast Tracking in certain cases, which does testing on sick patients before the drug has been approved. I'm sure they could make even more allowances, but the allowance they made for my friend and others with the same illness at the time, literally saved his life and others that received the drug during testing.


Leave a comment

You are commenting as guest.

FacebookTwitterDiggStumbleuponGoogle BookmarksRedditNewsvineLinkedIn